KalVista Pharmaceuticals (KALV) Change in Acquisitions & Divestments (2019 - 2025)

KalVista Pharmaceuticals' Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $41.7 million for Q3 2025.

• In Q3 2025, Change in Acquisitions & Divestments rose 9.02% year-over-year to $41.7 million; the TTM figure through Jul 2025 stood at $149.0 million (up 52.35% YoY), while the FY2025 annual figure was $122.5 million, up 16.74% from the prior year.
• Change in Acquisitions & Divestments came in at $41.7 million for Q3 2025 at KalVista Pharmaceuticals, up from $20.2 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $65.0 million in Q2 2022 to a low of $7.9 million in Q2 2021.
• A 5-year average of $34.0 million and a median of $36.2 million in 2021 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments soared 718.34% in 2022 and tumbled 77.41% in 2024, its largest moves.
• KalVista Pharmaceuticals' Change in Acquisitions & Divestments stood at $50.7 million in 2021, then plunged by 59.95% to $20.3 million in 2022, then surged by 60.33% to $32.5 million in 2023, then soared by 50.24% to $48.9 million in 2024, then declined by 14.73% to $41.7 million in 2025.
• According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $41.7 million, $20.2 million, and $48.9 million for Q3 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison